DrugPatentWatch Database Preview
Patent: 8,568,766
» See Plans and Pricing
Summary for Patent: 8,568,766
| Title: | Peptides and peptide mimetics to treat pathologies associated with eye disease |
| Abstract: | This invention provides novel active agents (e.g. peptides, small organic molecules, amino acid pairs, etc.) peptides that ameliorate one or more symptoms of eye disease and/or other pathologies characterized by an inflammatory response. In certain embodiment, the peptides resemble a G* amphipathic helix of apolipoprotein J. The agents are highly stable and readily administered via an oral route or via intraocular injection. |
| Inventor(s): | Anantharamaiah; Gattadahalli M. (Birmingham, AL), Fogelman; Alan M. (Beverly Hills, CA), Navab; Mohamad (Los Angeles, CA), Rudolf; Martin (Lubeck, DE) |
| Assignee: | |
| Application Number: | 12/027,728 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,568,766 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,568,766
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech | LUCENTIS | ranibizumab | INJECTABLE; INJECTION | 125156 | 001 | 2006-06-30 | Start Trial | 2020-08-24 | RX | search | ||
| Genentech | AVASTIN | bevacizumab | VIAL; INTRAVENOUS | 125085 | 002 | 2004-02-26 | Start Trial | 2020-08-24 | RX | search | ||
| Genentech | AVASTIN | bevacizumab | VIAL; INTRAVENOUS | 125085 | 001 | 2004-02-26 | Start Trial | 2020-08-24 | RX | search | ||
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 8,568,766
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 200601638 | Start Trial |
| South Africa | 200710184 | Start Trial |
| World Intellectual Property Organization (WIPO) | 0215923 | Start Trial |
| World Intellectual Property Organization (WIPO) | 0220645 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2004034977 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
